Kraig Biocraft Laboratories (KBLB) Payables (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Payables across 16 years of filings, most recently posting $9.8 million for Q4 2025.

• Payables for Q4 2025 came in at $9.8 million, up 9.14% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.8 million (up 9.14% YoY), and the FY2025 annual result was $9.8 million, up 9.14% from the prior year.
• Payables came in at $9.8 million for Q4 2025 at Kraig Biocraft Laboratories, up from $2.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $12.5 million in Q3 2023 to a low of $1.1 million in Q4 2021.
• The 5-year median for Payables is $2.2 million (2022), against an average of $4.4 million.
• Across the five-year window, Payables surged 571.91% in 2022 and tumbled 82.99% in 2024, its largest moves.
• Kraig Biocraft Laboratories' Payables stood at $1.1 million in 2021, then soared by 571.91% to $7.3 million in 2022, then plunged by 70.56% to $2.2 million in 2023, then surged by 316.94% to $9.0 million in 2024, then advanced by 9.14% to $9.8 million in 2025.
• The last three Payables figures came in at $9.8 million (Q4 2025), $2.1 million (Q3 2025), and $1.9 million (Q2 2025), per Business Quant data.